文献速递妇科生殖医学

表皮生长因子通过上调透明质酸合酶2和透明质酸促进子宫内膜异位症基质细胞迁移和侵袭

Epidermal growth factor promotes stromal cells migration and invasion via up-regulation of hyaluronate synthase 2 and hyaluronan in endometriosis.
PubMed 文献 · Fertil Steril · 2020-08-03

本研究探讨透明质酸合酶2(HAS2)和透明质酸在子宫内膜异位症进展及表皮生长因子(EGF)诱导的细胞运动改变中的作用。病例对照实验和体外原代细胞培养研究,纳入21例I/II期内异症、33例III/IV期伴子宫内膜瘤和32例无内异症女性。结果发现III/IV期内异症患者血清EGF和透明质酸浓度更高;EGF上调HAS2和透明质酸表达及细胞迁移侵袭,阻断EGFR可消除这些效应,HAS2敲低减弱基底和EGF诱导的透明质酸表达及细胞运动改变。

要点

  • III/IV期子宫内膜异位症患者血清EGF和透明质酸浓度高于I/II期或无内异症女性。
  • 异位病灶中pEGFR和HAS2表达高于在位子宫内膜。
  • EGF通过ERK1/2和AKT信号通路上调HAS2和透明质酸,促进基质细胞迁移和侵袭。

核心结论

  • EGF增加子宫内膜异位症相关透明质酸及其合酶HAS2的表达,两者介导EGF诱导的子宫内膜异位症患者基质细胞迁移和侵袭。

研究设计与样本

  • 病例对照实验研究和体外原代细胞培养研究,纳入21例I/II期内异症、33例III/IV期伴子宫内膜瘤和32例无内异症女性。
  • 收集血清、在位子宫内膜和/或异位子宫内膜组织,从卵巢子宫内膜瘤女性分离培养原代在位子宫内膜基质细胞(EuESCs)和异位卵巢子宫内膜异位基质细胞(OvESCs),分别给予或不给予EGF处理。

主要发现

  • III/IV期内异症女性血清EGF和透明质酸浓度高于I/II期或无内异症女性。
  • EGFR、pEGFR、HAS2和CD44免疫定位于在位子宫内膜和异位病灶,异位病灶中pEGFR和HAS2表达高于在位子宫内膜。
  • EGF处理上调EuESCs和OvESCs中HAS2和透明质酸表达以及细胞迁移和侵袭,药物阻断EGFR可消除这些效应。
  • 小干扰RNA敲低HAS2减弱基底和EGF诱导的透明质酸表达及细胞运动改变。
  • ERK1/2和AKT信号通路显示为EGF调控HAS2和透明质酸表达以及细胞迁移和侵袭的下游通路。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate the role(s) of hyaluronan synthase 2 (HAS2) and hyaluronan in disease progression of endometriosis and epidermal growth factor (EGF)-induced motility changes of endometriotic cells. DESIGN: A case-control experimental study and in vitro primary cell culture study. SETTING: University hospital-affiliated research centers. PATIENTS: A total of 21 women with stage I/II endometriosis, 33 women with stage III/IV endometriosis with endometrioma, and 32 women without endometriosis were included in our study. INTERVENTIONS: Serum, eutopic endometrial tissues, and/or ectopic endometriotic tissues were collected. Primary eutopic endometrial stromal cells (EuESCs) and ectopic ovarian endometriotic stromal cells (OvESCs) were isolated and cultured from women with ovarian endometrioma, and then treated with or without EGF. MAIN OUTCOME MEASURES: The concentrations of EGF and hyaluronan in serum were analyzed by enzyme-linked immunosorbent assay. The expressions and localizations of EGF receptor (EGFR), phosphorylated-(p)EGFR, HAS2, and hyaluronan receptor CD44 in tissues were examined by immunohistochemistry. The mRNA and protein levels of HAS2 in EuESCs and OvESCs were examined by reverse transcription-quantitative polymerase chain reaction (RT-qPCR) and western blot, respectively, and the concentrations of hyaluronan in conditioned medium were examined by enzyme-linked immunosorbent assay (ELISA). Cell motility was evaluated by transwell migration/invasion assays. RESULTS: Serum EGF and hyaluronan concentrations were higher in women with stage III/IV endometriosis than in women with stage I/II or without endometriosis. EGFR, pEGFR, HAS2, and CD44 were immunolocalized in eutopic endometrium and ectopic endometriotic lesions, and the expressions of pEGFR and HAS2 were elevated in ectopic endometriotic lesions compared to eutopic endometrium. Treatment with EGF upregulated HAS2 and hyaluronan expression as well as cell migration and invasion in both EuESCs and OvESCs, and pharmaceutical blocking of EGFR abolished these effects. In addition, knockdown of HAS2 by small interfering RNA attenuated both basal and EGF-induced hyaluronan expression and cell motility changes. Notably, ERK1/2 and AKT signaling pathways were shown to be downstream of EGF in regulating HAS2 and hyaluronan expression as well as cell migration and invasion. CONCLUSION: EGF increased the expression of endometriosis-associated hyaluronan and its synthase HAS2, both of which mediated EGF-induced stromal cell migration and invasion in women with endometriosis.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Zhan H, Peng B, Ma J, et al. Epidermal growth factor promotes stromal cells migration and invasion via up-regulation of hyaluronate synthase 2 and hyaluronan in endometriosis. Fertil Steril. 2020. PMID: 32762950. doi:10.1016/j.fertnstert.2020.05.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。